Skip to content

Evidence Hub

Publication
Feb 14, 2023

Comparison of External Control Arm Critiques in Regulatory and Health Technology Assessment of Oncology Submissions

Objectives: The development of accelerated approval programs for high morbidity and unmet ...
Start Reading
Publication
Feb 14, 2023

Erratum: high-dimensional propensity score adjustment in studies of treatment effects using health care claims data

In the article titled “High-dimensional Propensity Score Adjustment in Studies of ...
Start Reading
Publication
Feb 14, 2023

Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases

Background Health care databases are natural sources for estimating prevalence and ...
Start Reading
Publication
Feb 14, 2023

Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large US administrative claims database

BACKGROUND: Chronic kidney disease (CKD) is one of the most common complications of type ...
Start Reading
Publication
Feb 14, 2023

[REPEAT] Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions. Nature Communications

Studies that generate real-world evidence on the effects of medical products through ...
Start Reading
Publication
Feb 14, 2023

Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort Study

Objectives To investigate prevalence estimates and incidence rates (IRs) for SSc and ...
Start Reading
Publication
Feb 14, 2023

Impact of season and other factors on initiation, discontinuation and switching of systemic drug therapy in patients with psoriasis - a retrospective study

This study investigated whether systemic drug prescribing for psoriasis varies by season ...
Start Reading
Publication
Feb 14, 2023

Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2is

Background: Clinical practice guidelines recommend sodium-glucose co-transporter 2 ...
Start Reading
Publication
Feb 14, 2023

High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes: real-world evidence from a US claims database

Background Chronic kidney disease (CKD), a serious complication of type 2 diabetes (T2D) ...
Start Reading
Publication
Feb 14, 2023

High-dimensional propensity scores for empirical covariate selection in secondary database studies

Real-world evidence used for regulatory, payer, and clinical decision-making requires ...
Start Reading
Publication
Feb 14, 2023

Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance

Decision-makers have become increasingly interested in incorporating real-world evidence ...
Start Reading
Publication
Feb 14, 2023

Key Learnings from ICER’s Real World Evidence Reassessment Pilot

Health technology assessment (HTA) agencies are considering adopting a lifecycle approach ...
Start Reading
Publication
Feb 14, 2023

Safety of Intravenous Pantoprazole Sodium in Pediatric Patients Aged 1 Month to < 1 Year: A Real-World Retrospective Cohort Study

Objective To estimate the incidence rates (IR) of prespecified outcomes of interest in ...
Start Reading
Publication
Feb 14, 2023

Using Healthcare Databases to Replicate Trial Findings for Supplemental Indications: Adalimumab in Patients with Ulcerative Colitis

Regulators wish to understand whether real world evidence can be used for secondary ...
Start Reading
Publication
Feb 14, 2023

Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis

Introduction Many fibrosing interstitial lung diseases (ILDs) develop a chronic ...
Start Reading
Publication
Feb 14, 2023

Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score–matched cohort analysis

Background Escalation to triple therapy (long-acting muscarinic antagonist/β2-agonist, ...
Start Reading
Publication
Feb 14, 2023

Clinical features and diagnosis of multiple myeloma: a population-based cohort study in primary care

Objectives Patients with multiple myeloma (MM) experience significant delays in diagnosis ...
Start Reading
Publication
Feb 14, 2023

Real‐world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a UK‐based electronic health records database

Purpose We evaluated the reproducibility of a study characterizing newly-diagnosed ...
Start Reading
Publication
Feb 14, 2023

Fournier's gangrene in patients with type 2 diabetes using second‐line antidiabetic medications

Cases of a rare but serious infection called Fournier's gangrene have been reported with ...
Start Reading
Publication
Feb 14, 2023

COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients

Background The COVID-19 pandemic remains a significant global threat. However, despite ...
Start Reading
Publication
Feb 14, 2023

Chronic opioid use and complication risks in women with endometriosis: a cohort study in US administrative claims

Background Women with endometriosis are prescribed opioids for pain relief but may be ...
Start Reading
Publication
Feb 14, 2023

Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study

Objective To compare real-world effectiveness and safety of direct oral anticoagulants ...
Start Reading
Publication
Feb 14, 2023

Availability of comparative real-world evidence research in Medicare patients: Implications for CMS drug price negotiations

To evaluate the availability of published comparative real-world evidence (RWE) studies ...
Start Reading
Publication
Feb 14, 2023

Statin Use and Severe Acute Liver Injury Among Patients with Elevated Alanine Aminotransferase

While serious liver injury among statin users is extremely rare, baseline liver enzyme ...
Start Reading